Today: 21 May 2026
SPAC ETF Rises After SpaceX Moves Toward Its Old SPCX Ticker
21 May 2026
2 mins read

SPAC ETF Rises After SpaceX Moves Toward Its Old SPCX Ticker

New York, May 20, 2026, 18:26 EDT

The SPAC and New Issue ETF closed higher on Wednesday under its new ticker, SPCK, as fresh U.S. listing activity gave the small fund a new read on risk appetite — and SpaceX filed for an estimated $75 billion IPO under the fund’s former SPCX symbol. SPCK ended the regular session at $22.09, up 0.64%.

The ticker point matters because the fund only moved from SPCX to SPCK on April 7. Tuttle Capital said then that the change had no effect on the fund’s investment objective, strategy, fees or expenses.

More broadly, SPCK is a niche gauge for a market that has been trying to reopen. A SPAC, or special purpose acquisition company, is a listed cash shell that seeks a merger with a private business; an IPO, or initial public offering, is a company’s first sale of shares to the public. The fund says it invests at least 80% of assets in SPAC units and shares, plus companies that completed an IPO within the last two years.

The fund is still small. Its website showed $7.14 million in net assets, 41 holdings and 325,000 shares outstanding as of May 19, with a market price of $21.95 and a net asset value — the per-share value of the fund’s holdings and cash — of $21.96.

The new-issue tape was busy. Renaissance Capital said Research Alliance III, a blank-check company formed by RA Capital, priced a $75 million IPO on Wednesday; FutureCorp Space Acquisition 1 filed for a $200 million SPAC IPO targeting space and defense; and JAB Acquisition I filed on Tuesday for a $150 million IPO aimed at marketing technology.

The fund’s move was modest beside other risk assets. The Renaissance IPO ETF rose about 3.9%, while the SPDR S&P 500 ETF Trust gained about 1.0%, according to market data. The S&P 500 added 1.1% and the Nasdaq composite rose 1.5% as yields and oil prices fell.

The pipeline is getting attention from larger deals, not just blank-check issuers. Reuters reported that OpenAI is preparing to confidentially file for a U.S. IPO in the coming weeks, while SpaceX’s filing is expected to put portfolio managers in front of two large private-company stories at once. “Simultaneous filings also force portfolio managers to evaluate both companies side by side,” IPOX Vice President Kat Liu told Reuters. Reuters

Lincoln International’s debut added another sign of demand. The investment bank was valued at about $2.3 billion after its shares opened 12.6% above the IPO price, and Chief Executive Rob Brown told Reuters: “That ice dam is melting.” Reuters

Regulation is also shifting. The U.S. Securities and Exchange Commission on Tuesday proposed changes that it said would make share issuance and reporting easier for public companies, including raising the “large accelerated filer” threshold to $2 billion from $700 million and widening access to shelf offerings, which let companies pre-register securities and sell them later when market conditions suit. Reuters

But the SPAC part of the trade is not a straight read on those proposals. Reuters reported that the SEC changes would not apply to blank-check companies, penny-stock firms or shell companies, leaving SPAC sponsors dependent on investor appetite, deal quality and redemption levels.

There is also fund-specific risk. SPCK’s own disclosure says short-term performance is not a good guide to future returns and that limited research coverage can add volatility; the fund also notes that holdings and allocations can change. Its top holdings as of May 19 included FG Imperii Acquisition Corp, Twelve Seas Investment Co III and Art Technology Acquisition Corp.

For now, SPCK gives investors a thinly traded, actively managed window into SPACs and recent IPOs at a moment when the new-issue calendar is filling again. The next test is whether this week’s filings become priced deals — and whether the largest IPO candidates draw capital toward the whole sector, or away from smaller shells.

Stock Market Today

  • Nvidia (NVDA) Reports Strong Q1 2026 with Revenue Surging 85% and Robust Guidance
    May 20, 2026, 6:31 PM EDT. Nvidia (NASDAQ:NVDA) delivered an 85.2% year-on-year revenue increase to $81.62 billion in Q1 CY2026, beating analyst expectations by 3.5%. Its adjusted earnings per share of $1.87 also surpassed forecasts by 5.4%. The company's non-GAAP EBITDA margin rose to 69.2%, supported by operating margins climbing to 65.6% from 49.1% a year ago. Nvidia provided Q2 revenue guidance of $91 billion, 5.7% above consensus, signaling accelerating demand amid growth in AI infrastructure. CEO Jensen Huang highlighted the rapid expansion of AI factories as a key growth driver. The firm's five-year compounded annual revenue growth rate sits at 67.4%, with recent acceleration reflecting strong market positioning in semiconductors, despite cyclical industry risks.

Latest articles

SPAC ETF Rises After SpaceX Moves Toward Its Old SPCX Ticker

SPAC ETF Rises After SpaceX Moves Toward Its Old SPCX Ticker

21 May 2026
New York, May 20, 2026, 18:26 EDT The SPAC and New Issue ETF closed higher on Wednesday under its new ticker, SPCK, as fresh U.S. listing activity gave the small fund a new read on risk appetite — and SpaceX filed for an estimated $75 billion IPO under the fund’s former SPCX symbol. SPCK ended the regular session at $22.09, up 0.64%. The ticker point matters because the fund only moved from SPCX to SPCK on April 7. Tuttle Capital said then that the change had no effect on the fund’s investment objective, strategy, fees or expenses. More broadly, SPCK
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes
Previous Story

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

Go toTop